ScrutarSign up free

GANX Institutional Ownership

Top institutional (13F) holders of GANX and activist (13D/G) positions, sourced from SEC EDGAR.

Institutional owners
14
Institutional value
$5.72M
Top holder
DME Capital Management, LP

Couldn’t find the data you were looking for?

We haven’t added Gain Therapeutics, Inc.’s filings yet. We add companies and filings all the time.

Track GANX and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.

Top holders

HolderFiledValue
DME Capital Management, LPinvestment advisorAug 14, 2026$1.15M
Vanguard Capital Managementinvestment advisorAug 13, 2026$974.9K
GEODE CAPITAL MANAGEMENT, LLCinvestment advisorAug 12, 2026$921.4K
BlackRock, Inc.holding companyAug 7, 2026$558.2K
UBS Group AGinvestment advisorAug 13, 2026$436.5K
CITADEL ADVISORS LLCinvestment advisorSep 1, 2026$396.3K
STATE STREET CORPORATIONinvestment advisorSep 22, 2026$319.8K
SUSQUEHANNA INTERNATIONAL GROUP, LLPinvestment advisorAug 14, 2026$289.9K
MORGAN STANLEYinvestment advisorAug 13, 2026$255.7K
JANE STREET GROUP, LLCholding companyAug 14, 2026$197.4K
NORTHERN TRUST CORPinvestment advisorAug 13, 2026$196.9K
WELLS FARGO & COMPANY/MNinvestment advisorAug 14, 2026$19.1K
JPMORGAN CHASE & COinvestment advisorAug 12, 2026$3.4K
CITIGROUP INCinvestment advisorMay 11, 2026$2

Never miss a GANX filing.

Get an email when GANX files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Source: SEC EDGAR Schedule 13D / 13G and 13F filings.